Literature DB >> 20356323

Benign prostatic hyperplasia: counting the cost of its management.

Roger S Kirby1, Mike Kirby, John M Fitzpatrick.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20356323     DOI： 10.1111/j.1464-410X.2010.09274.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  13 in total

1.  A Prospective Study of Physical Activity, Sedentary Behavior, and Incidence and Progression of Lower Urinary Tract Symptoms.

Authors:  Alison M Mondul; Edward Giovannucci; Elizabeth A Platz
Journal:  J Gen Intern Med       Date:  2020-04-28       Impact factor: 5.128

2.  Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men.

Authors:  Elizabeth A Platz; Corinne E Joshu; Alison M Mondul; Sarah B Peskoe; Walter C Willett; Edward Giovannucci
Journal:  J Urol       Date:  2012-06-15       Impact factor: 7.450

Review 3.  Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room.

Authors:  Bradley C Gill; James C Ulchaker
Journal:  Curr Urol Rep       Date:  2018-07-19       Impact factor: 3.092

4.  A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.

Authors:  Alison M Mondul; Edward Giovannucci; Elizabeth A Platz
Journal:  J Urol       Date:  2013-09-25       Impact factor: 7.450

5.  Cost of illness of medically treated benign prostatic hyperplasia in Hungary.

Authors:  Fanni Rencz; Ágnes Kovács; Valentin Brodszky; László Gulácsi; Zalán Németh; Gábor János Nagy; János Nagy; István Buzogány; Géza Böszörményi-Nagy; Attila Majoros; Péter Nyirády
Journal:  Int Urol Nephrol       Date:  2015-06-21       Impact factor: 2.370

6.  Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.

Authors:  Phillip Ertel; Burkay Adalig; Ipek Demircan; Belinda Lartey; Michael J Manyak
Journal:  Int J Clin Pract       Date:  2016-10       Impact factor: 2.503

7.  Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.

Authors:  Ran Pang; Xin-Yao Zhou; Xiangling Wang; Bin Wang; Xue-Lai Yin; Hai Bo; Jae Hung Jung
Journal:  Cochrane Database Syst Rev       Date:  2021-02-10

8.  Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.

Authors:  Paul Toren; David Margel; Girish Kulkarni; Antonio Finelli; Alexandre Zlotta; Neil Fleshner
Journal:  BMJ       Date:  2013-04-15

9.  Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.

Authors:  Cameron Edwin Alexander; Malo Mf Scullion; Muhammad Imran Omar; Yuhong Yuan; Charalampos Mamoulakis; James Mo N'Dow; Changhao Chen; Thomas Bl Lam
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

Review 10.  Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression.

Authors:  Carl W White; Jin Han Xie; Sabatino Ventura
Journal:  Organogenesis       Date:  2013-05-14       Impact factor: 2.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.